Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$18.57

0.89 (5.03%)

12:05
10/03/16
10/03
12:05
10/03/16
12:05

Exact Sciences rises after NCQA updates colorectal cancer screening measure

Reference Link

  • 04

    Oct

  • 26

    Oct

  • 15

    Nov

EXAS Exact Sciences
$18.57

0.89 (5.03%)

08/10/16
BARD
08/10/16
NO CHANGE
BARD
Outperform
HCSC coverage of Cologuard could pressure other payors, says Baird
Baird analyst Catherine Ramsey noted that Health Care Service Corporation, or HCSC, which is the nation's largest customer-owned health insurance company as the owner of several Blue Cross and Blue Shield systems, has posted a pending medical policy that would provide coverage for Exact Sciences' Cologuard. Coverage of the test by HCSC would be a "significant win" and could help pressure other payors to update their policies, said Ramsey, who keeps an Outperform rating on Exact Sciences shares.
08/10/16
CHLM
08/10/16
NO CHANGE
Target $26
CHLM
Buy
Craig-Hallum positive on HCSC, Florida Blue coverage of Exact Sciences Cologuard
Craig-Hallum analyst Bill Bonello notes that two payors, namely Health Care Service Corporation, or HCSC, and Florida Blue posted updated Medical Policies indicating that Exact Sciences' Cologuard may be "medically necessary" for colorectal cancer screening. The analyst believes this is a "very positive" indicator of how other payors will interpret the positive recommendation from the U.S. Preventive Services Task Force issued in June. Further, he sees Exact Sciences as well positioned to become standard of care for colon cancer screening, which could be a $3B-$5B opportunity over time. Bonello reiterates a Buy rating and $26 price target on the shares.
08/15/16
ADAM
08/15/16
NO CHANGE
Target $24
ADAM
Buy
Exact Sciences price target raised to $24 from $19 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $24 from $19 citing expectations of ongoing commercial momentum in the second half of the year coupled with new commercial payor wins. Massaro raised its numbers based on recent payor wins and the belief Q3 guidance feels achievable. Massaro reiterated his Buy rating on Exact Sciences shares.
09/01/16
CHLM
09/01/16
NO CHANGE
Target $26
CHLM
Buy
Exact Sciences Cologuard to receive commercial payor coverage, says Craig-Hallum
After eviCore suggested that Exact Sciences' Cologuard may be considered for colorectal cancer screening once every three years, Craig-Hallum analyst Bill Bonello says he believes that at least one large health insurer, Highmark, has already elected to follow this policy. The analyst continues to believe that Cologuard will receive broad commercial payer coverage in light of the 2016 USPSFT final colorectal cancer screening recommendation and that increased payer coverage will drive increased test volumes. He reiterates a Buy rating and $26 price target on the shares.

TODAY'S FREE FLY STORIES

XLP

Consumer Staples Sector SPDR

$55.50

0.5 (0.91%)

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$74.41

0.73 (0.99%)

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$90.68

1.57 (1.76%)

, VA

Virgin America

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Hot Stocks
Alaska Air and Virgin America to move into terminal 7 at JFK airport »

Alaska Airlines (ALK) and…

ALK

Alaska Air

$90.68

1.57 (1.76%)

VA

Virgin America

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 04

    May

  • 10

    May

IWM

iShares Trust Russell 2000 Index Fund

$138.92

1.71 (1.25%)

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$43.28

0.21 (0.49%)

08:17
04/25/17
04/25
08:17
04/25/17
08:17
Hot Stocks
Coca-Cola CEO says Q1 results 'in line with our plan' »

Muhtar Kent, Chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 09

    May

DIA

Diamonds Fund ETF

$207.38

2.13 (1.04%)

08:17
04/25/17
04/25
08:17
04/25/17
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$237.17

2.58 (1.10%)

08:17
04/25/17
04/25
08:17
04/25/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$23.68

0.52 (2.25%)

08:17
04/25/17
04/25
08:17
04/25/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$79.75

1.14 (1.45%)

08:16
04/25/17
04/25
08:16
04/25/17
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

NASDAQ 100 Index Tracking Stock

$134.16

1.6 (1.21%)

08:16
04/25/17
04/25
08:16
04/25/17
08:16
Technical Analysis
NASDAQ 100 Index Tracking Stock: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

08:16
04/25/17
04/25
08:16
04/25/17
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$5,508.03

65.9844 (1.21%)

08:16
04/25/17
04/25
08:16
04/25/17
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSTX

Mast Therapeutics

$0.14

0.0081 (6.23%)

08:15
04/25/17
04/25
08:15
04/25/17
08:15
Hot Stocks
Mast Therapeutics and Savara announce anticipated merger exchange ratio »

Mast Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

CATB

Catabasis Pharmaceuticals

$1.50

0.05 (3.45%)

08:14
04/25/17
04/25
08:14
04/25/17
08:14
Hot Stocks
Catabasis Pharmaceuticals announce 'favorable' results in MoveDMD trial »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

MVIS

MicroVision

$2.87

0.26 (9.96%)

08:14
04/25/17
04/25
08:14
04/25/17
08:14
Technical Analysis
MicroVision hits new 52-week high in pre-market trading »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

PAAS

Pan American Silver

$17.81

-0.28 (-1.55%)

08:13
04/25/17
04/25
08:13
04/25/17
08:13
Hot Stocks
Pan American Silver subsidiary to acquire Patagonia Gold's project »

Pan American Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 10

    May

LLY

Eli Lilly

$83.42

1.53 (1.87%)

08:13
04/25/17
04/25
08:13
04/25/17
08:13
Hot Stocks
Eli Lilly sees two more product launches possible by year end 2018 »

Eli Lilly sees the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 07

    May

  • 31

    May

PPG

PPG

$108.01

2.07 (1.95%)

08:11
04/25/17
04/25
08:11
04/25/17
08:11
Hot Stocks
PPG announces price increases for packaging coatings »

PPG announced that it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASM

Avino Silver & Gold Mines

$1.48

-0.07 (-4.52%)

08:11
04/25/17
04/25
08:11
04/25/17
08:11
Hot Stocks
Avino Silver & Gold Mines announces results from ten holes in Avino Mine »

Avino Silver & Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHR

Whirlpool

$174.80

3.29 (1.92%)

08:11
04/25/17
04/25
08:11
04/25/17
08:11
Recommendations
Whirlpool analyst commentary  »

Whirlpool should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

GALT

Galectin Therapeutics

$3.20

0.11 (3.56%)

08:10
04/25/17
04/25
08:10
04/25/17
08:10
Hot Stocks
Galectin granted Composition of Matter patent in Japan for GR-MD-02 »

Galectin Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$45.90

1.81 (4.11%)

08:10
04/25/17
04/25
08:10
04/25/17
08:10
Hot Stocks
Sanofi: Most patients treated with Lemtrada in Phase III study did not relapse »

Sanofi Genzyme, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

08:10
04/25/17
04/25
08:10
04/25/17
08:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

LLNW

Limelight Networks

$2.75

0.1 (3.77%)

08:09
04/25/17
04/25
08:09
04/25/17
08:09
Technical Analysis
Limelight Networks moves sharply higher following results, price target raised »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$115.57

-0.33 (-0.28%)

, LVS

Las Vegas Sands

$57.65

0.27 (0.47%)

08:09
04/25/17
04/25
08:09
04/25/17
08:09
Recommendations
Wynn Resorts, Las Vegas Sands, MGM Resorts analyst commentary  »

Macau forecasts raised at…

WYNN

Wynn Resorts

$115.57

-0.33 (-0.28%)

LVS

Las Vegas Sands

$57.65

0.27 (0.47%)

MGM

MGM Resorts

$29.00

0.59 (2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 27

    Apr

  • 31

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.